These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 32739850)
61. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia. Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381 [TBL] [Abstract][Full Text] [Related]
62. Soluble thrombomodulin to evaluate the severity and outcome of community-acquired pneumonia. Yin Q; Liu B; Chen Y; Zhao Y; Li C Inflammation; 2014 Aug; 37(4):1271-9. PubMed ID: 24573987 [TBL] [Abstract][Full Text] [Related]
63. Initial serum lactate level is associated with inpatient mortality in patients with community-acquired pneumonia. Gwak MH; Jo S; Jeong T; Lee JB; Jin YH; Yoon J; Park B Am J Emerg Med; 2015 May; 33(5):685-90. PubMed ID: 25791153 [TBL] [Abstract][Full Text] [Related]
64. The prognostic value of serum albumin levels and respiratory rate for community-acquired pneumonia: A prospective, multi-center study. Zhao L; Bao J; Shang Y; Zhang Y; Yin L; Yu Y; Xie Y; Chen L; Zheng Y; Xu Y; Gao Z PLoS One; 2021; 16(3):e0248002. PubMed ID: 33662036 [TBL] [Abstract][Full Text] [Related]
65. Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia. Christ-Crain M; Stolz D; Jutla S; Couppis O; Müller C; Bingisser R; Schuetz P; Tamm M; Edwards R; Müller B; Grossman AB Am J Respir Crit Care Med; 2007 Nov; 176(9):913-20. PubMed ID: 17702966 [TBL] [Abstract][Full Text] [Related]
66. Comparison of three predictive rules for assessing severity in elderly patients with CAP. Ochoa-Gondar O; Vila-Corcoles A; Rodriguez-Blanco T; Ramos F; de Diego C; Salsench E; Gil D; Daniel J; Palacios L; Blade J Int J Clin Pract; 2011 Nov; 65(11):1165-72. PubMed ID: 21951687 [TBL] [Abstract][Full Text] [Related]
67. Prognostic value of procalcitonin in community-acquired pneumonia. Schuetz P; Suter-Widmer I; Chaudri A; Christ-Crain M; Zimmerli W; Mueller B; Eur Respir J; 2011 Feb; 37(2):384-92. PubMed ID: 20595156 [TBL] [Abstract][Full Text] [Related]
68. Increased plasma AACT level as an indicator of poor prognosis in patients hospitalised with community-acquired pneumonia: a multicentre prospective cohort study. Zhao L; Xi W; Shang Y; Gao W; Bian W; Chen X; Xue J; Xu Y; Gong P; Guo S; Gao Z BMC Infect Dis; 2024 Sep; 24(1):946. PubMed ID: 39251931 [TBL] [Abstract][Full Text] [Related]
69. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia. Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525 [TBL] [Abstract][Full Text] [Related]
70. Comprehensive analysis of prognostic factors in hospitalized patients with pneumonia occurring outside hospital: Serum albumin is not less important than pneumonia severity assessment scale. Miyazaki H; Nagata N; Akagi T; Takeda S; Harada T; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Fujita M; Watanabe K J Infect Chemother; 2018 Aug; 24(8):602-609. PubMed ID: 29628384 [TBL] [Abstract][Full Text] [Related]
71. Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Loke YK; Kwok CS; Niruban A; Myint PK Thorax; 2010 Oct; 65(10):884-90. PubMed ID: 20729235 [TBL] [Abstract][Full Text] [Related]
72. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Masiá M; Gutiérrez F; Shum C; Padilla S; Navarro JC; Flores E; Hernández I Chest; 2005 Oct; 128(4):2223-9. PubMed ID: 16236878 [TBL] [Abstract][Full Text] [Related]
74. Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia. España PP; Capelastegui A; Quintana JM; Bilbao A; Diez R; Pascual S; Esteban C; Zalacaín R; Menendez R; Torres A J Infect; 2010 Feb; 60(2):106-13. PubMed ID: 19961875 [TBL] [Abstract][Full Text] [Related]
75. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Christ-Crain M; Morgenthaler NG; Stolz D; Müller C; Bingisser R; Harbarth S; Tamm M; Struck J; Bergmann A; Müller B Crit Care; 2006; 10(3):R96. PubMed ID: 16805922 [TBL] [Abstract][Full Text] [Related]
76. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Singanayagam A; Aliberti S; Cillóniz C; Torres A; Blasi F; Chalmers JD Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28890433 [TBL] [Abstract][Full Text] [Related]
77. Lactate levels and pneumonia severity index are good predictors of in-hospital mortality in pneumonia. Demirel B Clin Respir J; 2018 Mar; 12(3):991-995. PubMed ID: 28168816 [TBL] [Abstract][Full Text] [Related]
78. Short-term mortality of adult inpatients with community-acquired pneumonia: external validation of a modified CURB-65 score. Pflug MA; Tiutan T; Wesemann T; Nüllmann H; Heppner HJ; Pientka L; Thiem U Postgrad Med J; 2015 Feb; 91(1072):77-82. PubMed ID: 25618316 [TBL] [Abstract][Full Text] [Related]
79. Combining a Frailty Index Based on Laboratory Data and Pneumonia Severity Assessments to Predict In-Hospital Outcomes in Older Adults with Community-Acquired Pneumonia. Zan YM; Zheng TP; Wang Y; Shao JF; Wang ZY; Zhao WH; Wu JQ; Xu W J Nutr Health Aging; 2023; 27(4):270-276. PubMed ID: 37170434 [TBL] [Abstract][Full Text] [Related]